Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Shares Outstanding: 2020-2025

Historic Shares Outstanding for Verastem (VSTM) over the last 4 years, with Sep 2025 value amounting to $66.7 million.

  • Verastem's Shares Outstanding rose 65.79% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 65.79%. This contributed to the annual value of $44.8 million for FY2024, which is N/A change from last year.
  • Verastem's Shares Outstanding amounted to $66.7 million in Q3 2025, which was up 8.49% from $61.5 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Shares Outstanding ranged from a high of $66.7 million in Q3 2025 and a low of $15.4 million during Q4 2021.
  • In the last 3 years, Verastem's Shares Outstanding had a median value of $33.6 million in 2024 and averaged $38.4 million.
  • In the last 5 years, Verastem's Shares Outstanding decreased by 15.57% in 2021 and then skyrocketed by 128.91% in 2025.
  • Over the past 5 years, Verastem's Shares Outstanding (Quarterly) stood at $15.4 million in 2021, then rose by 8.23% to $16.7 million in 2022, then reached $25.3 million in 2023, then skyrocketed by 59.36% to $44.8 million in 2024, then skyrocketed by 65.79% to $66.7 million in 2025.
  • Its Shares Outstanding stands at $66.7 million for Q3 2025, versus $61.5 million for Q2 2025 and $51.5 million for Q1 2025.